About the Authors

Bohdan Nosyk

Affiliation BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada

Guillaume Colley

Affiliation BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada

Benita Yip

Affiliation BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada

Keith Chan

Affiliation BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada

Katherine Heath

Affiliation BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada

Viviane D. Lima

Affiliations BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada, Division of AIDS, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

Mark Gilbert

Affiliations Clinical Prevention Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada, School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada

Robert S. Hogg

Affiliations BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada, Faculty of Health Sciences, Simon Fraser University, Vancouver, British Columbia, Canada

P. Richard Harrigan

Affiliations BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada, Division of AIDS, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

Julio S. G. Montaner

jmontaner@cfenet.ubc.ca

Membership of the STOP HIV/AIDS Study Group is provided in the Acknowledgments.

Affiliations BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada, Division of AIDS, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

Competing Interests

Dr. JSGM has received grants from Abbott, Biolytical, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck and ViiV Healthcare. He is also supported by the Ministry of Health Services and the Ministry of Healthy Living and Sport, from the Province of British Columbia; through a Knowledge Translation Award from the Canadian Institutes of Health Research (CIHR); and through an Avant-Garde Award (No. 1DP1DA026182) from the National Institute of Drug Abuse, at the US National Institutes of Health. He has also received support from the International AIDS Society, United Nations AIDS Program, World Health Organization, National Institute on Drug Abuse, National Institutes of Health Research-Office of AIDS Research, National Institute of Allergy & Infectious Diseases, The United States President's Emergency Plan for AIDS Relief (PEPfAR), Bill & Melinda Gates Foundation, French National Agency for Research on AIDS & Viral Hepatitis (ANRS), Public Health Agency of Canada. These do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: BN RSH. Performed the experiments: BN GC BY. Analyzed the data: BN GC BY KC. Contributed reagents/materials/analysis tools: MG KH VL RSH PRH JSGM. Wrote the paper: BN GC BY KC MG KH VL RSH PRH JSGM.